Or maybe they won't help with it, but we would not care! ππ
Repurposing antipsychotic drugs offers a promising, cost-effective approach to cancer treatment. These medications, already tested for safety, could move swiftly into clinical trials and potentially enhance current therapies.
First-generation antipsychotics like haloperidol and trifluoperazine, as well as second-generation drugs like olanzapine, have shown anti-cancer effects, such as inducing cell death, halting tumor growth, and boosting the efficacy of chemotherapy agents.
While side effects and limited clinical trials remain challenges, the pre-clinical data suggest that with further research, these drugs might provide new treatment options for various cancer types.